SCHEMBL827658

SCHEMBL827658

CN1C=CN(C)C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3949428 0.96
SCHEMBL9201379 0.74
SCHEMBL31376068 0.73
SCHEMBL1925361 0.69
SCHEMBL329130 0.64
SCHEMBL8526388 0.61
Water SCHEMBL31012143 0.61
SCHEMBL13156410 0.61
SCHEMBL29205011 0.61
SCHEMBL26326511 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330255-B1 PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2020-12-09 EP claimed
EP-2828272-B1 CARBENE TRANSFER REAGENT UNIV JACOBS BREMEN GMBH (DE) 2016-10-19 EP claimed
EP-1924577-B1 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION NOVARTIS AG (CH) 2011-03-30 EP claimed
US-20100087444-A1 IMATINIB MESYLATE DR. REDDY'S LABORATORIES LTD. (IN) 2010-04-08 US claimed
EP-2120877-A2 IMATINIB MESYLATE Dr. Reddy's Laboratories Ltd. (IN) 2009-11-25 EP claimed
WO-2008112722-A2 IMATINIB MESYLATE DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-18 WO claimed
EP-0895991-A2 Halogenating agent Mitsui Chemicals, Inc. (JP) 1999-02-10 EP claimed
CN-118063349-A Cyclopropionamide substituted benzamide derivative and preparation method and application thereof 山东省联合农药工业有限公司 2024-05-24 CN disclosed
CN-118044519-A Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 科迪华农业科技有限责任公司 2024-05-17 CN disclosed
CN-117580586-A Fc glycan remodelling for site-specific antibody conjugation and uses thereof 马里兰大学帕克分校 2024-02-20 CN disclosed
CN-110072842-B Molecules having pesticidal utility, and intermediates, compositions and methods related thereto 科迪华农业科技有限责任公司 2024-02-02 CN disclosed
CN-117343124-A Visible light mediated cysteine-based polypeptides and protein chemical modification methods 上海交通大学 2024-01-05 CN disclosed
CN-113024481-B Preparation method of tartaric acid-derived chiral oxazolidine-2-thioketone 中南民族大学 2022-07-15 CN disclosed
EP-1531846-A4 CONJUGATES OF LIGAND, LINKER AND CYTOTOXIC AGENT AND RELATED COMPOSITIONS AND METHODS OF USE US GOV HEALTH & HUMAN SERV (US) 2006-04-19 EP disclosed
US-20050171014-A1 Conjugates of ligand linker and cytotoxic agent and related composition and methods of use GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) 2005-08-04 US disclosed
EP-1531846-A2 CONJUGATES OF LIGAND, LINKER AND CYTOTOXIC AGENT AND RELATED COMPOSITIONS AND METHODS OF USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-05-25 EP disclosed
CN-1557809-A Process for synthesis of chiral oxazolidine-2-thioketone compounds 中国科学院上海有机化学研究所 2004-12-29 CN disclosed
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
WO-2003072754-A2 CONJUGATES OF LIGAND, LINKER AND CYTOTOXIC AGENT AND RELATED COMPOSITIONS AND METHODS OF USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2003-09-04 WO disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 EP disclosed